Call Us Email Us Enquire with Us
Moving
the fino partners

Contingent Value Rights (CVRs): Bridging Valuation Gaps in Modern M&A Deals

Pricing the asset correctly is among the hardest parts of a merger or acquisition. The buyer does not want to pay too much for uncertain results; the seller wants to be rewarded for the future value of the company. In light of increasing innovation
Explore What we Do
Captcha

Others | By Andrew Smith | 2026-07-27 08:21:03

Pricing the asset correctly is among the hardest parts of a merger or acquisition. The buyer does not want to pay too much for uncertain results; the seller wants to be rewarded for the future value of the company. In light of increasing innovation dependence within many industries and economic uncertainties extending into 2026, it has gotten much harder to come up with a fair evaluation. It has made firms look into flexible deal terms that share risks but still allow for potential gains.

In this blog post, you will understand what Contingent Value Rights (CVRs) are, why they are relevant to modern mergers and acquisitions, how CVRs are recorded according to U.S. GAAP, what benefits and drawbacks they have, and why businesses use CVRs in acquisition deals.

Understanding Contingent Value Rights and Their Role in M&A

Disagreement about valuation has been the biggest challenge faced by acquiring companies. Although valuation models help predict future performance, many companies generate value through assets that may only be valuable in the event of uncertain future events. Contingent Value Rights provide an effective solution whereby a portion of the cost of acquisition is contingent upon the future outcome.

Why Traditional Valuations Often Fall Short

Assumptions are made concerning the future income of businesses, the demand for their products, regulatory approvals, acceptance among customers, and efficiency. Even though projections help understand how valuable a business could be in the future, they do not remove all uncertainties. The situation is aggravated if an enterprise has assets that have not fully realized their commercial potential.

For instance, a biotech firm may be working on the development of the drug that promises regulatory approval and makes the firm more valuable. An acquirer may consider the chance of getting regulatory approval less probable due to trials and government approval process. There should be a way to address this uncertainty issue.

What Are Contingent Value Rights (CVRs)?

Contingent Value Rights are contract terms under which the buyer will pay further amounts to the shareholders of the target firm contingent upon reaching certain milestones after closing the deal. The milestones can be related to obtaining certain approvals from regulatory authorities, achieving revenues and production levels, launching products, and other business events that occur over a defined period.

Instead of valuing uncertain future events at today's value, CVRs defer the payment of the purchase price contingent on the realization of such events. In this way, buyers mitigate risks and sellers have an opportunity to share in the value created by them.

Why CVRs Have Become More Relevant in 2026

In 2026, the environment for mergers and acquisitions will still be influenced by economic uncertainty, high interest rates, technological development through AI, improvements in the healthcare sector, and changing regulatory frameworks. This has led to increased disagreements regarding valuations and has made flexible acquisition structures a preferred option compared to traditional fixed price acquisitions.

Firms today are also buying companies that possess substantial intangible assets like proprietary software, artificial intelligence algorithms, intellectual property, renewables, and research pipelines. Many of these assets create value in the future, which is why CVRs have gained importance beyond being used exclusively in pharmaceutical acquisitions.

Where CVRs Deliver the Greatest Value

Not every acquisition benefits from contingent consideration. CVRs are particularly effective when future business performance depends on uncertain but measurable events that significantly influence valuation.

Industries Where CVRs Are Commonly Used

The industries of pharmaceuticals and life sciences still make up the largest users of CVRs. Pharmaceutical development takes several years of testing and approvals for bringing out profits. Thus, due to a possible high increase in the value of a business as well as possible total destruction, CVRs will provide an even division of risk between parties.

But by 2026, businesses from such industries as mining, energy, technology, renewable infrastructure, artificial intelligence, and advanced manufacturing will be increasingly utilizing this tool. The milestones of production, the obtaining of patents and licensing, the commercialization of software, and the finding of resources are all cases of uncertain future value.

Industry

Typical CVR Milestone

Pharmaceuticals

FDA or regulatory approval of a drug

Biotechnology

Successful completion of clinical trials

Technology

Commercial launch of AI products or software

Mining

Achievement of production targets

Renewable Energy

Completion of major infrastructure projects

Manufacturing

Meeting operational or revenue milestones

How CVRs Help Buyers and Sellers Reach Agreement

Acquisitions made in the traditional manner involve having both sides settle on an agreed purchase price even though they have different views regarding this matter. The CVR provides an alternative approach where the purchase price and rewards that come with future success are separated.

The buyer benefits because he is not likely to pay now for something that will never materialize while the seller is not locked out of the chance of getting more money if his expectations are fulfilled in the future.

Comparing Traditional Acquisitions with CVR-Based Transactions

The difference between conventional acquisitions and CVR-based structures highlights why these instruments have gained popularity.

Traditional Acquisition

Acquisition with CVRs

Fixed purchase price

Initial payment plus contingent payments

Buyer assumes most valuation risk

Risk shared between buyer and seller

Negotiations may become prolonged

Easier resolution of valuation disagreements

Limited flexibility

Highly customizable payment structure

Immediate pricing decisions

Future performance influences final value

Accounting, Risks, and the Future of CVRs

While CVRs add flexibility during the negotiating process, they also cause challenges to accounting and reporting processes. Both parties need to know the implications of these derivatives on their financial statements following an acquisition.

Accounting Treatment Under U.S. GAAP

According to ASC 805 – Business Combinations, contingent consideration is initially measured at its fair value on the date of the acquisition. According to the terms of the transaction, the company acquires the CVR as a liability or as an equity instrument.

If CVR is classified as a liability, then it needs to be remeasured on a periodic basis up until the payment is made. The difference in the estimated value of the liability is reflected on the income statement and hence results in volatility in profits. On the other hand, equity CVRs are usually not measured after their initial measurement. The fair value can be estimated using a discounted cash flow approach, probability of payments approach, or the option approach like the Black Scholes model.

Benefits and Challenges of Using CVRs

Apart from solving issues of valuation dispute, CVRs provide strategic advantages in the form of increased deal flexibility, incentive alignment, liquidity preservation for acquirers, and the ability to manage uncertainty while still being able to negotiate.

Yet, there are certain complications that arise along with these advantages. Milestone-based payment is not an easy task from both legal and financial points of view. Calculating the fair value will need sophisticated valuation techniques, and disputes can emerge either due to ambiguous milestones definition or unexpected external impact on performance.

Advantages

Challenges

Bridges valuation gaps

Complex legal agreements

Encourages successful deal completion

Difficult valuation assumptions

Preserves buyer liquidity

Ongoing fair value adjustments

Aligns incentives

Potential future disputes

Highly customizable

Increased accounting complexity

The Future Outlook for CVRs in M&A

Given the growing dependence of business models on intellectual property, digital assets, artificial intelligence, and innovations, there is little hope that valuation uncertainty can be eliminated. On the contrary, it is anticipated that companies will have to resort to flexible transaction designs to combine opportunities and financial prudence.

More and more investment bankers, corporate financiers, and accountants realize the potential of CVRs as an ideal means of structuring acquisitions of innovative and emerging technology businesses or companies that operate in volatile industries. Instead of being a narrowly defined instrument used exclusively by pharmaceutical firms, CVRs are gaining momentum and becoming a broader strategic tool used in M&A all over the world. The growing importance of fair value assessment, proper financial reporting, and incentive deal structure indicates that CVRs will play an important role in acquisitions in the coming years.

CVRs have revolutionized the way companies deal with valuation issues in cases of mergers and acquisitions. By tying a portion of the purchase price to future business success, CVRs allow the buyer to address uncertainties but still give the seller a chance to profit from the future success if certain benchmarks are reached.

Given that the trend of mergers and acquisitions will continue into 2026, companies involved in innovative sectors and those facing uncertain regulations and long lead times are likely to employ CVRs. Despite the need for good valuation, accountancy skills, and clear contractual agreements, this is one of the most viable ways of settling valuation issues.

Follow The Fino Partners for expert insights on accounting, bookkeeping, taxation, corporate finance, regulatory developments, and the latest business trends. Explore our resources to stay ahead of important financial changes and make confident, well-informed decisions.

Related Services

Frequently Asked Questions (FAQs)

CVRs are contractual rights that provide additional payments to the acquired company's shareholders if specific post-acquisition milestones or performance targets are achieved.

Drug approvals and clinical trials create significant valuation uncertainty. CVRs allow companies to defer part of the purchase price until those outcomes become known.

Under ASC 805, contingent consideration is initially measured at fair value. Liability-classified CVRs are subsequently remeasured, while equity-classified CVRs generally are not.

Beyond pharmaceuticals, CVRs are becoming more common in technology, renewable energy, mining, biotechnology, manufacturing, and other innovation-driven industries.

Major risks include inaccurate valuation assumptions, accounting complexity, unclear milestone definitions, and potential disputes over whether performance targets have been met.

CVRs reduce upfront valuation disagreements by allowing future performance to determine part of the acquisition price, creating a more balanced allocation of risk and reward between both parties.
Aishwarya-Agrawal

Andrew Smith

Andrew Smith is an experienced content writer with a strong focus on various financial niches including VCFO services, accounting, and bookkeeping. He has worked on multiple articles and papers on financial management and corporate finance, published in esteemed journals. Ankit's expertise and dedication to delivering precise and insightful content make him a trusted voice in the finance and accounting sector.

Why Choose The Fino Partners?

With Fino partners you get more than just accounting and bookkeeping in the USA. You get an accurate, clear process that makes you satisfied. We made money management easy so you can grow your business instead. The advantages of utilising Fino partners for accounting outsourcing USA are:

data security
the fino partner
the fino partner
finopartner
thefinopartner
fino partner
the fino partner
the fino partner

Get a Call Back

Request a callback from us for more inquiry, by filling out the details asked ahead

Captcha